During Wednesday’s Current trade, Shares of Aramark (NYSE:ARMK), lost -0.46% to $30.40.
Long gone are the days of institutional food service where colleges were only predictable to provide basic nourishment three times each day. Recently’s Gen Z college students want it all – locally grown, sustainable, healthy, customizable, convenient and trendy – all at a good value.
Aramark (NYSE: ARMK), who serves millions of college consumers every day on 500 campuses across the U.S. and Canada, has transformed its Higher Education food business from campus dining to campus culinary.
Culinary and Customized Options
Customization is the key for Gen Z. Younger consumers in general are more open to trying new and unique items and flavors contrast to older consumers. In fact, about half (47%) of Gen Zers (aged 18–21) say that they prefer to visit restaurants that offer new or innovative flavors and ingredients*.
Action stations are offered for meals so students can create their own omelets, stir fry, pasta, and noodle and burrito bowls. This means custom ingredients and flavors – everything from locally grown fruits and veggies to a wide variety of spices, seasoning and flavor profiles.
Aramark provides food, facilities, and uniform services to education, healthcare, business and industry, sports, leisure, and corrections clients primarily in North America. The company offers managed services, counting dining, catering, food service administration, convenience-oriented retail operations, grounds and facilities maintenance, custodial, energy and construction administration, and capital project administration. It also provides non-clinical support services, such as patient food and nutrition, and retail food services; and facilities services comprising clinical equipment maintenance, environmental, laundry and linen distribution, plant operations, planned/technical, energy and supply chain administration, purchasing, and central transportation.
Shares of AstraZeneca plc (ADR) (NYSE:AZN), inclined 1.85% to $30.84, during its current trading session.
Charles River Laboratories International, Inc. (CRL) declared that it has extended its initial three-year partnership with AstraZeneca (AZN) for an additional five-year period. Under the agreement, which extends into 2020, Charles River retains its position as AstraZeneca’s preferred planned partner for outsourced regulated safety assessment and development DMPK (drug metabolism and pharmacokinetics).
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. Its principal products comprise Crestor for the treatment of dyslipidaemia and hypercholesterolemia; Seloken/Toprol-XL to control hypertension, and heart failure and angina; Onglyza for diabetes mellitus; Iressa for non-small cell lung cancer; Faslodex for breast cancer in post-menopausal women; and Zoladex for prostate cancer, breast cancer, and certain benign gynaecological disorders.
ACE Limited (NYSE:ACE), during its Wednesday’s current trading session gained 1.01% to $100.73.
The Board of Directors of ACE Limited (ACE) recently declared a quarterly dividend equal to $0.67 per share, payable on October 21, 2015, to shareholders of record at the close of business on September 30, 2015. Dividend payments will be made in United States dollars by the company’s transfer agent. This will be the second installment as approved by the company’s shareholders on May 21, 2015.
ACE Limited, through its auxiliaries, provides a range of property and casualty insurance and reinsurance products worldwide. The company’s Insurance North American P&C segment offers casualty insurance, environmental, inland marine, professional risk, disaster protection, vacant land and building, and claims and risk administration services; homeowners, automobile, valuables, umbrella liability, and recreational marine insurance; and wholesale excess and surplus lines property, casualty, environmental, professional liability, inland marine, and product recall coverages.
Finally, STMicroelectronics NV (ADR) (NYSE:STM), gained 1.71%, to $7.12.
STMicroelectronics (STM), a global semiconductor leader serving customers across the spectrum of electronics applications, declared the STiD325 (codenamed Barcelona), its DOCSIS[1] 3.1 chipset for Broadband CPE[2] Cable Modems, embedded Media Terminal Adapters (eMTAs), and Gateways, in addition to for Video Gateways when associated to set-top-box chipsets. It is being demonstrated at CableLabs Summer Conference, August 2-5, 2015 in Keystone, Colorado, USA.
DOCSIS 3.1 has been engineered by CableLabs(R) to unleash the multi-gigabit data era on existing Hybrid Fiber-Coax (HFC) netoperates through improved spectral efficiency using OFDM[3] multi-carrier modulation combined with low-density parity-check-based Forward Error Correction.
Designed for economy and performance, Barcelona features solid technical capabilities:
- Very high performance using multiple 64-bit ARM(R) CPUs to deliver >10K DMIPS, line-rate networking support on every port, and hardware acceleration for routing and switching, allowing Multiple System Operators (MSOs) to build future-proof CPE platforms with plenty of headroom to support the field introduction of new services;
- Backward compatibility with DOCSIS 3.0 32×8 to allow a smooth, cost-effective transition to DOCSIS 3.1;
- Flexible architecture facilitating independent software development and software upgrades with minimal coupling between stacks, in addition to the introduction of new features like home surveillance and home automation; support of various Wi-Fi configurations;
- 28nm FD-SOI silicon technology, providing outstanding power efficiency at all operating levels, counting fan-less designs, together with highly-efficient RF and analog integration.
Presently sampling to lead customers, Barcelona comes with pre-integrated RDK-B software, counting DOCSIS and Packet-Cable stacks.
STMicroelectronics N.V. designs, develops, manufactures, and markets various semiconductor integrated circuits and discrete devices worldwide. The company offers a range of semiconductor products, counting discrete and standard commodity components, application-specific integrated circuits, full-custom devices and semi-custom devices, micro-electro-mechanical systems, microcontrollers, sensors, digital consumer products, imaging products, memory products, media application processors, and application-specific standard products for analog, digital, and mixed-signal applications, in addition to silicon chips and smartcards.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
